The Primary Oral Insulin Trial (POInT) investigates whether type 1 diabetes in at-risk children can be prevented through oral ...

Biocon Ltd's biosimilar arm recently announced it will supply insulin glargine pens to US-based non-profit Civica.(istockphoto) Biocon Biologics Ltd is aiming to expand its insulin portfolio in the US ...

Civica plans to distribute its insulin glargine to pharmacies across the United States for $45 for a box of five pens. “Through the partnership we formed with Civica more than six years ago, BCBSA and ...

Share on Pinterest Experts say California’s new affordable insulin program is a breakthrough for people with diabetes. Getty Images California has launched a program to manufacture and sell lower-cost ...

California will start selling low-cost insulin on Jan. 1, nearly three years after Gov. Gavin Newsom announced a plan to make lifesaving medications more affordable for folks with diabetes. The ...

A study using AAO's IRIS Registry demonstrates Eylea HD 8 mg improves vision in treatment-naive patients with wet age-related macular degeneration or diabetic macular edema with previously treated ...

California Gov. Gavin Newsom announces CalRx-branded insulin glargine pens available beginning Jan. 1, 2026, at a suggested retail price of no more than $55 per five-pack, or $11 per pen, during a ...

Californians will be able to buy low-cost, state-branded insulin next year, Gov. Gavin Newsom announced Thursday. The CalRX – California's program to develop and sell its own prescription medications ...

SACRAMENTO, Calif. — California is making history in health care. Governor Gavin Newsom announced Thursday that the state will become the first in the nation to offer state-branded insulin — part of ...

The state of California is teaming up with the nonprofit generic drug maker Civica Rx and Biocon Biologics to offer an interchangeable biosimilar insulin glargine pen for $11 beginning January 1, 2026 ...